Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints

High-performance metabolic analysis is emerging in the diagnosis and prognosis of breast cancer (BrCa). Still, advanced tools are in demand to deliver the application potentials of metabolic analysis. Here, we used fast nanoparticle-enhanced laser desorption/ionization mass spectrometry (NPELDI-MS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yida, Du, Shaoqian, Liu, Jun, Huang, Weiyi, Liu, Wanshan, Zhang, Mengji, Li, Ning, Wang, Ruimin, Wu, Jiao, Chen, Wei, Jiang, Mengyi, Zhou, Tianhao, Cao, Jing, Yang, Jing, Huang, Lin, Gu, An, Niu, Jingyang, Cao, Yuan, Zong, Wei-Xing, Wang, Xin, Qian, Kun, Wang, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944253/
https://www.ncbi.nlm.nih.gov/pubmed/35302894
http://dx.doi.org/10.1073/pnas.2122245119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944253/
https://www.ncbi.nlm.nih.gov/pubmed/35302894
http://dx.doi.org/10.1073/pnas.2122245119

Ejemplares similares